What it is: A copper-binding tripeptide closely related to GHK-Cu, studied for its potential effects on hair follicle biology and scalp tissue regeneration.
Research suggests: Preclinical research indicates it may activate follicle growth factors and extend the active growth phase of hair follicles.
Best for: Hair follicle and skin researchers
Key thing to know: Has a higher copper binding affinity than GHK-Cu but an even smaller evidence base; most data is preclinical.
What is AHK-Cu?
AHK-Cu (Ala-His-Lys-Cu) is a copper-binding tripeptide analog structurally related to GHK-Cu (glycyl-histidyl-lysine copper). While both peptides bind copper and share broad regenerative properties, AHK-Cu is distinguished by a higher binding affinity for copper ions and a more targeted research focus on hair follicle biology and scalp health.
The copper component is essential to its proposed activity. Copper is a required cofactor for enzymes involved in collagen and elastin synthesis, melanin production, and antioxidant defense. In follicle research, adequate copper delivery is studied as a factor in maintaining the anagen (growth) phase and preventing follicle miniaturization, the hallmark of androgenetic alopecia.
AHK-Cu appears most often in topical formulations in the research context, though some protocols explore subcutaneous application. It is of interest to researchers studying hair loss, skin tissue repair, and anti-aging interventions that target the extracellular matrix.
How it works.
In research, the proposed mechanism has several parts.
Hair follicle biology: AHK-Cu is studied for its interaction with follicle growth signaling, particularly a proposed role in modulating transforming growth factor-beta (TGF-beta). Elevated TGF-beta activity is linked to the catagen (regression) phase of the hair cycle and helps drive follicle miniaturization in pattern hair loss. Research suggests AHK-Cu may help shift the balance back toward growth-phase signaling.
Angiogenesis (VEGF): A second area of interest is vascular endothelial growth factor (VEGF) upregulation. Hair follicles in active growth require robust blood supply. Improved follicular vascularity through VEGF stimulation has been proposed as a mechanism by which copper peptides maintain follicle viability.
Wound-healing parallel: This is analogous to the mechanism studied in wound healing contexts for GHK-Cu.
Copper delivery: AHK-Cu also acts as a chaperone for copper ions, delivering them to copper-dependent enzymes at the follicle. These include lysyl oxidase, which crosslinks collagen and elastin, and superoxide dismutase (SOD), which protects follicle cells from oxidative damage. The proposed combined effect is an environment more supportive of active follicle function and less prone to stress-induced regression.
What the research shows.
The research evidence breaks down as follows.
Preclinical level: Most AHK-Cu research exists at the in vitro and small preclinical level. Cell culture studies have shown that AHK-Cu promotes proliferation of dermal papilla cells (the cells that govern follicle activity) and increases expression of growth-promoting factors. These are mechanistically consistent findings, but they are far from clinical validation.
Comparative studies: A small number of comparative studies have looked at copper peptides alongside minoxidil in preclinical studies, showing comparable or synergistic effects on hair count and follicle diameter. These studies are typically short duration, small sample size, and not independently replicated at scale. No large randomized controlled trials in humans have been published to date for AHK-Cu specifically.
GHK-Cu comparison: GHK-Cu, the closely related parent compound, has a somewhat stronger evidence base with more publications and a longer research history. Much of what is inferred about AHK-Cu draws on that broader copper peptide literature. AHK-Cu is considered a more targeted and potent variant in terms of copper affinity, but it has less total published research behind it.
Biomarkers to review first.
Research protocols for AHK-Cu typically reference the following biomarkers as baseline context. Testing these before exploring this peptide gives you and your healthcare provider the most relevant starting information.
What it's commonly researched with.
In research literature, AHK-Cu appears alongside compounds that address overlapping regenerative pathways. The combinations below represent what researchers have studied, not recommendations for use.